Great stuff all around. Eravacycline on track for NDA this year with Blockbuster potential. 2 new INDs this year. Company has cash to run through end of 2016. I really don't see how Tetraphase doesn't get acquired. These guys are flying under the radar at the moment with such a small market cap.
Fantastic company with a one of a kind product and platform, same deal with PCYC.
Why will it do any better for DED?
Verified by Canaccord Genuity analyst. Look it up. Far better for screening travelers and monitoring quarantine patients than checking a temperature. Best of all, stock has yet to run up, and has backing by large institutional holders like Orbimed. Oh, they are profitable too.
I wonder if that's the next announcement we get? The congressional hearing seemed to suggest that NewLink would be partnering up with some big pharma to help manufacture the Ebola vaccine.
You can see where this stock is headed. $100+
Do the math, with only 27 Million shares outstanding, and an agreement worth close to $1 Billion dollars, that adds close to $37/share of value to the stock price in a single day! That's unheard of.
You buy NLNK for the Vaccine and IBIO to treat those already infected.
NLNK is contracted to manufacture the leading Ebola candidate vaccine developed by Canada's National Microbiology Laboratory. See congressional hearing last week.
IBIO is providing the plant technology to Caliber Labs (private company in Texas) to manufacture Zmapp. See government announcement Friday.
You need a vaccine to protect the military and healthcare workers - NLNK. You need a treatment for those already infected - IBIO.
Hope that helps new investors.
Slides and video on cspan.
NewLink won't be able to make it fast enough. We're talking millions in revenue.
NewLink's Ebola vaccine is the only game in town. Maintain $50 target.
That's scary. There is no way this outbreak is contained. The CDC has lost complete control. The only thing that can stop this outbreak is mass vaccination. As things spiral out of control, there will be tremendous urgency to get a vaccination made available to the general public. As it stands NewLink seems to be the closest.